[ad_1]
According to him, only dexamethasone has been shown to be effective in treating serious diseases. He noted that experiments with hydroxychloroquine, which is considered a promising treatment for the virus, were recently stopped. Remdezivir and interferon have also not been shown to be effective in treating coronavirus.
Earlier, the head of the WHO had the idea of a massive immunity against the coronavirus. He explained that mass immunity is a term used during vaccination, in which the population can protect itself from the virus.
An epidemic of COVID-19 pneumonia caused by a new coronavirus was first reported in December 2019 in Wuhan. On March 11, the WHO announced that the situation could be characterized as a pandemic.
According to a WHO-backed study, the antiviral drug remdezivir, which is considered one of the most promising treatments for Covid-19, does little to prevent mortality from the disease.
Remdesivir, part of an experimental cocktail given to US President Donald Trump when he contracted the new coronavirus last month, is one of several drugs studied in a large study involving more than 11,000 people in 30 countries.
According to a study published Thursday night, the drug “had little or no effect on hospitalized COVID-19, as evidenced by overall mortality, initiation of ventilation, and length of hospital stay.”
Data not yet reviewed or published in a scientific journal appear to contradict at least two large studies in the United States showing that remdezivir can shorten hospital stays for COVID-19 patients.
Translation: BLIC
[ad_2]
